Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical diagnostics and treatment strategies for Philadelphia chromosome–like acute lymphoblastic leukemia

14 Jan 2020

Abstract excerpt

Philadelphia chromosome-like B-cell acute lymphoblastic leukemia (Ph-like ALL) accounts for 15% to 30% of B-cell acute lymphoblastic leukemia in older children, adolescents, and adults and is associated with high rates of conventional treatment failure and relapse. Current clinical trials are assessing the efficacy of the addition of tyrosine kinase inhibitors (TKIs) to chemotherapy for children and adults with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Lymphoblastic Leukemia research
Share to Childhood Cancer Survivors' Quality of Life
Share to Chronic Myeloid Leukemia Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31935290
DOI: 10.1182/bloodadvances.2019000163

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical diagnostics and treatment strategies for Philadelphia chromosome–like acute lymphoblastic leukemiaPMID 31935290Read ↗

Clinical screening for Ph-like ALL and the developing role of TKIs.Semantic proximity Read ↗

How I treat Philadelphia chromosome–like acute lymphoblastic leukemia in children, adolescents, and young adultsSemantic proximity Read ↗

Philadelphia chromosome–like acute lymphoblastic leukemiaSemantic proximity Read ↗

How I diagnose and manage Philadelphia chromosome-like acute lymphoblastic leukemiaSemantic proximity Read ↗

The Current Genomic and Molecular Landscape of Philadelphia-like Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

Beyond Philadelphia: 'Ph-like' B cell precursor acute lymphoblastic leukemias - diagnostic challenges and therapeutic promises.Semantic proximity Read ↗

Has Ph-like ALL Superseded Ph+ ALL as the Least Favorable Subtype?Semantic proximity Read ↗

Bridging the Gap: Cost-Effective Strategies for Detecting Ph-Like B-Lineage ALL in Resource-Limited Settings.Semantic proximity Read ↗

Genetic Alterations and Therapeutic Targeting of Philadelphia-Like Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

Advances in the Genetics and Therapy of Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

Integrative Insights into Philadelphia-like B-Cell Acute Lymphoblastic Leukemia: A Genetic and Molecular LandscapeSemantic proximity Read ↗

High Frequency and Poor Outcome of Philadelphia Chromosome–Like Acute Lymphoblastic Leukemia in AdultsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.